Please login to the form below

constipation

This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

Approval by China’s NMPA for adults with irritable bowel syndrome with constipation (IBS-C) opens up the country's huge market to the treatment. ... This approval is incredibly important as it brings a new option to treat some of the bothersome

Latest news

Shire bags US approval for constipation drug Motegrity

Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like
Immunology keeps Shire figures solid as Takeda takeover nears

HAE, prucalopride (SHP555) for chronic idiopathic constipation, and calaspargase pegol (SHP663) for the treatment of acute lymphoblastic leukaemia (ALL).
Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
NICE backs Allergan's IBS therapy Truberzi

includes Linzess (linaclotide) for IBS with constipation.
FDA fast-tracks Pfizer and Lilly's tanezumab

unpleasant side effects such as severe constipation.

More from news
Approximately 8 fully matching, plus 64 partially matching documents found.

Latest Intelligence

Erectile dysfunction, constipation, vaginal dryness and other laughing matters

Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile territory.
Taking a lean and careful approach

His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
Deal Watch March 2016

$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
Oral biologics delivery still elusive

years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
Medius Deal Watch table for March 2015

941. AstraZeneca / Daiichi Sankyo. Co-commercialisation US . Marketed Movantik (naloxegol) for opioid induced constipation.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

Ironwood appoints Edward Owens to board

irritable bowel syndrome and constipation.
Norgine’s Karen Hockey promoted to head of global marketing

Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation treatment Movicol since joining Norgine in 2011.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Senior Medical Writer: Competitive salary and benefits

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Account Director, Medical Education: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Director – Healthcare PR: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

PR Associate Director – Consumer Health & Beauty: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!: EXCELLENT DAY RATES AVAILABLE

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Senior Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...